Ryan Allway August 10th, 2021 Psychedelics Professor Sammis takes sabbatical to devote significant time toward developing psilocybin and cannabis intellectual property (IP) for Delic Labs VANCOUVER, BC, Aug. 10, 2021 /PRNewswire/ – Delic Corp Inc. (“DELIC” or the “Company“) (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform, today announced Professor Glenn Sammis, Scientific Advisor of... Read more